Mathematical modeling of the synergistic interplay of radiotherapy and immunotherapy in anti-cancer treatments

被引:1
|
作者
Castorina, Paolo [1 ,2 ,3 ]
Castiglione, Filippo [4 ,5 ]
Ferini, Gianluca [6 ,7 ]
Forte, Stefano [1 ]
Martorana, Emanuele [1 ]
Giuffrida, Dario [1 ]
机构
[1] Ist Oncol Mediterraneo, Genom & Mol Oncol Unit, Viagrande, Italy
[2] Ist Nazl Fis Nucl, Sez Catania, Catania, Italy
[3] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic
[4] Technol Innovat Inst, Biotech Res Ctr, Abu Dhabi, U Arab Emirates
[5] Natl Res Council Italy, Inst Appl Comp, Rome, Italy
[6] Radiotherapy Unit, REM Radioterapia, Viagrande, Italy
[7] Univ Kore Enna, Sch Med, Enna, Italy
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
mathematical modeling; Gompertz law; radiotherapy; immune response; abscopal effect; immunotherapy; SQUAMOUS-CELL CARCINOMA; T11 TARGET STRUCTURE; CANCER; RADIATION; GROWTH; DIFFERENTIATION; INHIBITION; METASTASES; BLOCKADE; IMMUNITY;
D O I
10.3389/fimmu.2024.1373738
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction While radiotherapy has long been recognized for its ability to directly ablate cancer cells through necrosis or apoptosis, radiotherapy-induced abscopal effect suggests that its impact extends beyond local tumor destruction thanks to immune response. Cellular proliferation and necrosis have been extensively studied using mathematical models that simulate tumor growth, such as Gompertz law, and the radiation effects, such as the linear-quadratic model. However, the effectiveness of radiotherapy-induced immune responses may vary among patients due to individual differences in radiation sensitivity and other factors.Methods We present a novel macroscopic approach designed to quantitatively analyze the intricate dynamics governing the interactions among the immune system, radiotherapy, and tumor progression. Building upon previous research demonstrating the synergistic effects of radiotherapy and immunotherapy in cancer treatment, we provide a comprehensive mathematical framework for understanding the underlying mechanisms driving these interactions.Results Our method leverages macroscopic observations and mathematical modeling to capture the overarching dynamics of this interplay, offering valuable insights for optimizing cancer treatment strategies. One shows that Gompertz law can describe therapy effects with two effective parameters. This result permits quantitative data analyses, which give useful indications for the disease progression and clinical decisions.Discussion Through validation against diverse data sets from the literature, we demonstrate the reliability and versatility of our approach in predicting the time evolution of the disease and assessing the potential efficacy of radiotherapy-immunotherapy combinations. This further supports the promising potential of the abscopal effect, suggesting that in select cases, depending on tumor size, it may confer full efficacy to radiotherapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Activation of dendritic cells by targeted DNA: a potential addition to the armamentarium for anti-cancer immunotherapy
    Laursen, Marlene Fyrstenberg
    Kofod-Olsen, Emil
    Agger, Ralf
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (11) : 1875 - 1880
  • [42] The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma
    Yu, Cheng-Chan
    Huang, Sung-Ying
    Chang, Shu-Fang
    Liao, Kuan-Fu
    Chiu, Sheng-Chun
    MOLECULES, 2020, 25 (10):
  • [43] Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics
    Bapiro, Tashinga E.
    Hayeshi, Rose
    Dandara, Collet
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
    Duskey, Jason Thomas
    Rinaldi, Arianna
    Ottonelli, Ilaria
    Caraffi, Riccardo
    De Benedictis, Chiara Alessia
    Sauer, Ann Katrin
    Tosi, Giovanni
    Vandelli, Maria Angela
    Ruozi, Barbara
    Grabrucker, Andreas Martin
    PHARMACEUTICS, 2022, 14 (07)
  • [45] Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment
    Yoo, Sun
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    Choi, Jonggi
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (04) : 898 - 907
  • [46] Combining concurrent radiotherapy and immunotherapy for synergistic effects in recurrent endometrial cancer-A case report
    Chepkemoi, Luiza
    Ajayi, Oluwaseyi
    Anabaraonye, Nancy
    Balogun, Onyinye D.
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 44
  • [47] Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
    Franco, Rafael
    Rivas-Santisteban, Rafael
    Navarro, Gemma
    Reyes-Resina, Irene
    CELLS, 2021, 10 (11)
  • [48] Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma
    Chakwizira, Arthur
    Ahlstedt, Jonatan
    Redebrandt, Henrietta Nittby
    Ceberg, Crister
    BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1087)
  • [49] Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy
    Bazett, Mark
    Costa, Amanda M.
    Bosiljcic, Momir
    Anderson, Rebecca M.
    Alexander, Matthew P.
    Wong, Stephanie W. Y.
    Dhanji, Salim
    Chen, Jenny M. H.
    Pankovich, Jim
    Lam, Stephen
    Sutcliffe, Simon
    Gunn, Hal
    Kalyan, Shirin
    Mullins, David W.
    ONCOIMMUNOLOGY, 2018, 7 (03):
  • [50] Imaging of T-cells and their responses during anti-cancer immunotherapy
    Krekorian, Massis
    Fruhwirth, Gilbert O.
    Srinivas, Mangala
    Figdor, Carl G.
    Heskamp, Sandra
    Witney, Timothy H.
    Aarntzen, Erik H. J. G.
    THERANOSTICS, 2019, 9 (25): : 7924 - 7947